VolitionRX Ltd.
(NYSE Amex Equities : VNRX)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Medical Specialties
symbolcompany%chnglast%shortavg$volume
DXCMDexCom, Inc. 4.56%378.318.2%$1034.33m
ABTAbbott Laboratories 3.17%95.020.8%$681.99m
BDXBecton, Dickinson & Co. 2.27%246.971.0%$635.38m
DHRDanaher Corp. 1.51%166.440.7%$595.38m
MDTMedtronic Plc 0.61%98.740.6%$552.61m
TMOThermo Fisher Scientific, Inc. 1.81%348.941.0%$507.16m
INOInovio Pharmaceuticals, Inc. 10.49%14.756.3%$439.97m
BSXBoston Scientific Corp. 1.36%37.981.1%$409.30m
ISRGIntuitive Surgical, Inc. 1.34%580.032.4%$370.20m
SYKStryker Corp. 0.23%195.791.3%$362.87m
WSTWest Pharmaceutical Services, Inc. 5.30%216.941.6%$307.41m
ALGNAlign Technology, Inc. -1.43%245.626.4%$296.78m
BAXBaxter International, Inc. 2.00%89.961.8%$262.76m
EWEdwards Lifesciences Corp. 1.09%224.561.2%$220.18m
QDELQuidel Corp. 4.65%175.007.7%$217.06m

Company Profile

VolitionRX Ltd. is a multi-national life sciences company, which engages in the development of blood-based cancer tests to help diagnose a range of cancers. Its products include the Nucleosomics platform that identifies and measures nucleosomes in the bloodstream or other bodily fluid. The company was founded on August 5, 2010 and is headquartered in Austin, TX.